Zobrazeno 1 - 10
of 10
pro vyhledávání: '"EFFECTS Trial Study Grp"'
Autor:
Koster, E.J. de, Geus-Oei, L.F. de, Brouwers, A.H., Dam, E.W.C.M. van, Dijkhorst-Oei, L.T., Engen-van Grunsven, A.C.H. van, Hout, W.B. van den, Klooker, T.K., Netea-Maier, R.T., Snel, M., Oyen, W.J.G., Vriens, D., EfFECTS Trial Study Grp
Publikováno v:
EfFECTS trial study group 2022, ' [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules : a blinded, randomised controlled multicentre trial ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 6, pp. 1970-1984 . https://doi.org/10.1007/s00259-021-05627-2
European Journal of Nuclear Medicine and Molecular Imaging, 49, 6, pp. 1970-1984
European Journal of Nuclear Medicine and Molecular Imaging, 49(6), 1970-1984. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 49(6), 1970-1984. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 49, 1970-1984
European journal of nuclear medicine and molecular imaging, 49(6), 1970-1984. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 49, 1970-1984. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 49, 6, pp. 1970-1984
European Journal of Nuclear Medicine and Molecular Imaging, 49(6), 1970-1984. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 49(6), 1970-1984. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 49, 1970-1984
European journal of nuclear medicine and molecular imaging, 49(6), 1970-1984. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 49, 1970-1984. SPRINGER
Purpose To assess the impact of an [18F]FDG-PET/CT-driven diagnostic workup to rule out malignancy, avoid futile diagnostic surgeries, and improve patient outcomes in thyroid nodules with indeterminate cytology. Methods In this double-blinded, random
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Koster, E.J. de, Husson, O., Dam, E.W.C.M. van, Mijnhout, G.S., Netea-Maier, R.T., Oyen, W.J.G., Snel, M., Geus-Oei, L.F. de, Vriens, D., EfFECTS Trial Study Grp
Objective: This study assessed the health-related quality of life (HRQoL) in patients undergoing 2-[18F]fluoro-2-deoxy-D-glucose (FDG)-PET/CT for an indeterminate (Bethesda III/IV) thyroid nodule. FDG-PET/CT accurately rules out malignancy and preven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10693::cfd970d75f3ddf1506959a1c63dc9a82
https://hdl.handle.net/1887/3563123
https://hdl.handle.net/1887/3563123
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Koster, E.J. de, Noortman, W.A., Mostert, J.M., Booij, J., Brouwer, C.B., Keizer, B. de, Klerk, J.M.H. de, Oyen, W.J.G., Velden, F.H.P. van, Geus-Oei, L.F. de, Vriens, D., EfFECTS Trial Study Grp
Publikováno v:
EfFECTS trial study group 2022, ' Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 7, pp. 2174-2188 . https://doi.org/10.1007/s00259-022-05712-0
European Journal of Nuclear Medicine and Molecular Imaging, 49, 2174-2188. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 49(7), 2174-2188. Springer Verlag
European journal of nuclear medicine and molecular imaging, 49(7), 2174-2188. Springer Verlag
European journal of nuclear medicine and molecular imaging, 49(7), 2174-2188. Springer
European Journal of Nuclear Medicine and Molecular Imaging, 49, 2174-2188
European Journal of Nuclear Medicine and Molecular Imaging, 49, 7, pp. 2174-2188
European Journal of Nuclear Medicine and Molecular Imaging, 49, 2174-2188. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 49(7), 2174-2188. Springer Verlag
European journal of nuclear medicine and molecular imaging, 49(7), 2174-2188. Springer Verlag
European journal of nuclear medicine and molecular imaging, 49(7), 2174-2188. Springer
European Journal of Nuclear Medicine and Molecular Imaging, 49, 2174-2188
European Journal of Nuclear Medicine and Molecular Imaging, 49, 7, pp. 2174-2188
Purpose To evaluate whether quantitative [18F]FDG-PET/CT assessment, including radiomic analysis of [18F]FDG-positive thyroid nodules, improved the preoperative differentiation of indeterminate thyroid nodules of non-Hürthle cell and Hürthle cell c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b09e01b10f8a1d812d06f001f4329a
https://research.vumc.nl/en/publications/bf9061e9-0c46-4303-99f6-bb8b70554a71
https://research.vumc.nl/en/publications/bf9061e9-0c46-4303-99f6-bb8b70554a71
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Koster, E.J. de, Vriens, D., Aken, M.O. van, Dijkhorst-Oei, L.T., Oyen, W.J.G., Peeters, R.P., Schepers, A., Geus-Oei, L.F. de, Hout, W.B. van den, EfFECTS Trial Study Grp
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 49, 10, pp. 3452-3469
European Journal of Nuclear Medicine and Molecular Imaging. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging
EfFECTS trial study group 2022, ' FDG-PET/CT in indeterminate thyroid nodules : cost-utility analysis alongside a randomised controlled trial ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 10, pp. 3452-3469 . https://doi.org/10.1007/s00259-022-05794-w
European Journal of Nuclear Medicine and Molecular Imaging, 49(10), 3452-3469. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 49, 3452-3469
European Journal of Nuclear Medicine and Molecular Imaging, 49(10), 3452-3469. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging
EfFECTS trial study group 2022, ' FDG-PET/CT in indeterminate thyroid nodules : cost-utility analysis alongside a randomised controlled trial ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 10, pp. 3452-3469 . https://doi.org/10.1007/s00259-022-05794-w
European Journal of Nuclear Medicine and Molecular Imaging, 49(10), 3452-3469. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 49, 3452-3469
European Journal of Nuclear Medicine and Molecular Imaging, 49(10), 3452-3469. Springer-Verlag
Purpose To evaluate cost-effectiveness of an [18F]FDG-PET/CT-driven diagnostic workup as compared to diagnostic surgery, for thyroid nodules with Bethesda III/IV cytology. [18F]FDG-PET/CT avoids 40% of futile diagnostic surgeries for benign Bethesda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9939ef92bffd2ac982723d214b1ba717
https://repository.ubn.ru.nl/handle/2066/283305
https://repository.ubn.ru.nl/handle/2066/283305
Autor:
Koster, E.J. de, Engen-van Grunsven, A.C.H. van, Bussink, J., Frielink, C., Geus-Oei, L.F. de, Kusters, B., Peters, H., Oyen, W.J.G., Vriens, D., EFFECTS Trial Study Grp
Publikováno v:
On behalf of the EFFECTS trial study group 2022, ' [18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules ', Molecular Imaging and Biology . https://doi.org/10.1007/s11307-022-01776-4
Molecular Imaging and Biology, 25, 3, pp. 483-494
Molecular Imaging and Biology. SPRINGER
Molecular Imaging and Biology
Molecular Imaging and Biology, 25, 483-494
Molecular imaging and biology : MIB. Springer New York
Molecular Imaging and Biology. Springer New York
Molecular Imaging and Biology, 25, 3, pp. 483-494
Molecular Imaging and Biology. SPRINGER
Molecular Imaging and Biology
Molecular Imaging and Biology, 25, 483-494
Molecular imaging and biology : MIB. Springer New York
Molecular Imaging and Biology. Springer New York
Purpose The current study explored the association between 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) uptake and the quantitative expression of immunohistochemical markers related to glucose metabolism, hypoxia, and cell proliferation in benign and m
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.